These 10 Stocks Bleed Heavily

5. Astera Labs, Inc. (NASDAQ:ALAB)

Astera Labs fell for a third day on Monday, shedding 5.82 percent to close at $90.32 apiece as investors repositioned portfolios ahead of the expected release of its earnings performance.

According to the company, it will release its financial and operating results on August 5, 2025, after the market closes.

For the second quarter of the year, Astera Labs, Inc. (NASDAQ:ALAB) earlier said that it expects revenues to settle within a range of $170 million to $175 million with gross margin of approximately 74 percent.

Operating expenses are expected to range between $113 million and $115 million, while diluted earnings per share were pegged at $0.10 to $0.11.

In the first quarter of the year, Astera Labs, Inc. (NASDAQ:ALAB) swung to a net income of $31.8 million from a $93-million net loss in the same period last year.

Revenues more than doubled to $159 million from $65 million year-on-year.